...
首页> 外文期刊>Journal of clinical laboratory analysis. >Comparative evaluation of a new chemiluminiscent assay and an ELISA for the detection of IgM against measles
【24h】

Comparative evaluation of a new chemiluminiscent assay and an ELISA for the detection of IgM against measles

机译:新型化学发光检测法和ELISA检测麻疹IgM的比较评估

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The primary test for the laboratory confirmation of measles is immunoglobulin M (IgM) serology. It is therefore important to evaluate new commercial measles IgM immunoassays to ensure high-quality measles diagnostic testing. The purpose of this study was to evaluate the diagnostic performance of LIAISON IgM measles (DiaSorin, Saluggia, Italy), a new automated chemiluminescence immunoassay (CLIA), in comparison with enzyme immunoassay (EIA) Enzygnost (Siemens, Marburg, Germany). Methods: Sensitivity was examined using a panel of measles laboratory confirmed sera; specificity was addressed by testing sera from healthy populations and subjects with infections that may interfere with measles IgM serology. Results: The diagnostic performances of the two assays were very similar: both Enzygnost EIA and LIAISON CLIA performed with a sensitivity of 93.7% and 98.8%, whereas the specificity was 96.8% and 97.9%, respectively. Conclusion: We concluded that LIAISON IgM measles can be a good alternative to the other immunoassay for laboratory measles confirmation.
机译:背景:用于实验室确认麻疹的主要测试是免疫球蛋白M(IgM)血清学。因此,重要的是评估新的商业性麻疹IgM免疫测定,以确保高质量的麻疹诊断测试。这项研究的目的是评估与酶免疫法(EIA)Enzygnost(Siemens,Marburg,德国)相比,新型自动化学发光免疫分析法(CLIA)LIAISON IgM麻疹(DiaSorin,意大利萨鲁贾)的诊断性能。方法:使用一组麻疹实验室确诊的血清检查敏感性。通过检测健康人群和感染可能会干扰麻疹IgM血清学的受试者的血清来解决特异性。结果:两种测定的诊断性能非常相似:Enzygnost EIA和LIAISON CLIA的灵敏度均为93.7%和98.8%,而特异性分别为96.8%和97.9%。结论:我们得出结论,LIAISON IgM麻疹可以替代其他免疫测定,用于实验室麻疹确诊。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号